<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/612A624E-81E8-4695-8283-3B43A7A38E18"><gtr:id>612A624E-81E8-4695-8283-3B43A7A38E18</gtr:id><gtr:name>Institute of Ageing and Chronic Disease</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Ludwig Institute for Cancer Research</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/612A624E-81E8-4695-8283-3B43A7A38E18"><gtr:id>612A624E-81E8-4695-8283-3B43A7A38E18</gtr:id><gtr:name>Institute of Ageing and Chronic Disease</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/822EF551-6FD0-41CA-85FA-3D914B94AE76"><gtr:id>822EF551-6FD0-41CA-85FA-3D914B94AE76</gtr:id><gtr:firstName>Sarah</gtr:firstName><gtr:surname>De Val</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/D742E9B1-A4F5-4657-80DD-F6293C03A7F7"><gtr:id>D742E9B1-A4F5-4657-80DD-F6293C03A7F7</gtr:id><gtr:firstName>George</gtr:firstName><gtr:surname>Bou-Gharios</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=BB%2FL020238%2F1"><gtr:id>2F396BE6-5F18-47F4-AADD-C3397A578CBE</gtr:id><gtr:title>Regulatory pathways controlling venous identity</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/L020238/1</gtr:grantReference><gtr:abstractText>The circulatory system of mammals is dependent on the formation of two distinct types of blood vessel, arteries and veins. The differences between these two blood vessel types arise due to alternative molecular signals early on in development. However, very little is known about these signals and how vein-specific genes are switched on in veins and off in arteries. Understanding this process is crucial for understanding and treating cardiovascular disease. For example, veins are often used to replace damaged arteries in coronary bypass surgery but often do not correctly adapt, and defective arterial-venous differentiation can lead to enlarged blood vessels at risk of catastrophic ruptures.

This study will look at regions of DNA called enhancers. These enhancer regions control whether a gene is on or off through the binding of proteins called transcription factors. We have found two enhancers which can switch genes on specifically in veins. This project aims to find what transcription factors bind to, and control, these vein-specific enhancers, and to understand what external signals cause this to happen. We will also use these gene switches to make an animal model capable of deleting any gene of interest specifically from veins.</gtr:abstractText><gtr:technicalSummary>This project will use the identification, analysis and characterisation of two novel venous-specific gene enhancers and their cognate binding transcription factors to understand the transcriptional and signalling pathways that regulate venous identity. While research clearly demonstrates that venous identity in endothelial cells is actively acquired, very little is known about the pathways that control this process. Ephb4 and COUP-TFII play essential roles in the specification and differentiation of veins, yet the manner in which their expression is regulated in venous endothelial cells is not known. In fact, it is still unclear whether their transcription is actively stimulated in veins, or repressed in arteries. Interpreting the results of signalling experiments is still challenging, due to a lack of even basic knowledge of venous gene regulation. The project proposed here will expand our knowledge of venous gene regulation by identifying and analysing enhancers driving Ephb4 and Coup-TFII expression in venous endothelial cells, delineate the key cis-motifs and trans-factors that regulate these enhancers in an unbiased manner, and discern the vascular signalling pathways upstream of this regulation.</gtr:technicalSummary><gtr:potentialImpactText>Virtually nothing is known about how venous endothelial cells become specified and differentiation. Consequently, this research is anticipated to have a major influence in the vascular developmental biology field and far beyond. This work will be of interest to a wide range of academics, described in detail in the Academic Beneficiary section. In addition, this research will provide key insights into how venous identity is both acquired and maintained, which is anticipated to open new avenues of research into mechanisms that may alter blood vessel identity for therapeutical benefits. For example, this work will be of interest to teams looking to manipulate cells to take on an endothelial, venous or arterial fate with the aim of assisting in repair after ischemic damage. 
In addition, although the proposed project is in basic research, understanding how blood vessels take on, and potential can loose, venous identify has potential interest to health care professionals. For example, veins are often used to repair damaged arteries in the heart, and this research may illuminate mechanisms beneficial or detrimental to the survival, and adaptability, of these grafts. The identification of key factors directing venous fate may also provide novel biomarkers to assess the differentiation status of vessels after vascular disease or surgery, and to identify cases of venous graft failure.</gtr:potentialImpactText><gtr:fund><gtr:end>2017-12-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2014-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>518152</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Institute of Ageing and Chronic Disease</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Musculoskeletal Biology</gtr:department><gtr:description>George</gtr:description><gtr:id>E6D1CC1F-623A-4575-AC0B-B53F580C595E</gtr:id><gtr:impact>We have two funded project grants utilizing data from this collaboration (MRC and BBSRC).
We have three papers published as co-authors.</gtr:impact><gtr:partnerContribution>George Bou-Gharios and his team at the Kennedy Institute (now part of University of Oxford) generate high-quality transgenic mice for us.</gtr:partnerContribution><gtr:piContribution>We provide know-how in in-silico enhancer prediction, and generate Tol2-mediated zebrafish transgenics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Behind the headlines - Museum outreach</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>CCD6E51F-5858-449E-8A1D-20AAD43CC10E</gtr:id><gtr:impact>The Museum of Natural History in Oxford runs many activities to try and engage the public with scientific research, including their regular 'Super Science Saturdays' events. Last autumn, as part of a special themed Super Science Saturday called 'Behind The Headlines', a team of scientists from mine and Roger Patient's lab in the MRC Molecular Haematology Unit created a series of different activities to explain the science behind the headline: 'How tiny fish could hold the key to blood cancer treatment'. Over 2,500 visitors attended the event, which included numerous other activities. Approximately half of those in attendence were estimated to be school age</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://wimmblog.com/2017/02/06/the-science-behind-the-headlines/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>work experience</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>6C0BC1F4-17CD-4265-A6AD-0103C0C22625</gtr:id><gtr:impact>Hosted 6th formers for work experience in our lab</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>oxford science festival</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>43406C25-83B8-49F9-BF72-B877919D2227</gtr:id><gtr:impact>Participated in NDM presentation at festival, talked about research with public</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>13000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Centre of Research Excellence, Oxford Pump Priming Grant</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>University of Oxford</gtr:fundingOrg><gtr:fundingRef>RE/13/1/30181</gtr:fundingRef><gtr:id>DE550CC1-81DD-4485-9F5D-E61C1154EB04</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-12-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Athena</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>7A43637C-C05C-4D47-9B09-10334CC77A36</gtr:id><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Ethical review</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>0648410C-38A5-4AF9-95F3-C9CC7CF2C512</gtr:id><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Arterial and angiogenic specific Cre model</gtr:description><gtr:id>515B55D2-2DC0-4F12-A1E0-C863BF6FFA3B</gtr:id><gtr:impact>None yet</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>dll4-cre</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Zebrafish in which the venous endothelium is specifically expressing GFP</gtr:description><gtr:id>A288B964-02F8-4446-8E05-49248A99BCC3</gtr:id><gtr:impact>This vein specific GFP fish provides an invaluable resource to many research groups</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>coup-fish</gtr:title><gtr:type>Model of mechanisms or symptoms - non-mammalian in vivo</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Transgenic mouse in which venous endothelial cells are marked by LacZ reporter gene</gtr:description><gtr:id>373D256A-689D-4C3D-A2AB-F2E212D3CBEE</gtr:id><gtr:impact>none yet</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Eph mouse</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2017</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Transgenic mice in which venous and lymphatic endothelial cells are labelled by LacZ reporter gene</gtr:description><gtr:id>BFFC220F-5ACA-4373-AE46-1E6B29E6EE26</gtr:id><gtr:impact>None yet</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>coup mouse</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2017</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>fish expressing GFP in veins only</gtr:description><gtr:id>FD217D9C-5FA2-4A0C-A669-6BB2FD42759E</gtr:id><gtr:impact>Paper in preparation</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>ephb4 fish</gtr:title><gtr:type>Model of mechanisms or symptoms - non-mammalian in vivo</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Enhancer that specifically drives gene expression in veins</gtr:description><gtr:id>AAD2FE47-A112-49C4-9C02-02B09F098DE0</gtr:id><gtr:impact>none yet</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>coup-plasmid</gtr:title><gtr:type>Model of mechanisms or symptoms - non-mammalian in vivo</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B909ED10-771A-499D-BB99-8A33A26FBAAD"><gtr:id>B909ED10-771A-499D-BB99-8A33A26FBAAD</gtr:id><gtr:title>An Intronic Flk1 Enhancer Directs Arterial-Specific Expression via RBPJ-Mediated Venous Repression.</gtr:title><gtr:parentPublicationTitle>Arteriosclerosis, thrombosis, and vascular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ef88b6631f13dd0dd6a32483a4f4e1b7"><gtr:id>ef88b6631f13dd0dd6a32483a4f4e1b7</gtr:id><gtr:otherNames>Becker PW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1079-5642</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/L020238/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>C23BE70F-1EF6-4CC7-88B0-841CB18DD875</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Genetics &amp; development</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>9898EFC8-73AB-4E1E-A207-04A486D9F1A9</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Animal developmental biology</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>CC10CC12-1D16-48BD-8F66-6A64A651DEAB</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Gene action &amp; regulation</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>